CEO total pay
$32,194,326
Brenton L. Saunders · 2025
Say on pay
Not disclosed
Use Ask for the underlying narrative
CEO pay ratio
Not in CD&A
Median employee: $50,904
Compensation committee
CD&ATalent and Compensation Committee
Per the latest proxy
Filings indexed: 2 · 2026 · 2025
Executive pay
What did they pay them?
From the Summary Compensation Table. Pay mix and YoY are computed from these rows.
| Executive | Role | TotalYoY | Pay mix | Salary | Stock | Cash incentive | Other |
|---|---|---|---|---|---|---|---|
Brenton L. Saunders2025 compensation | Chairman of the Board and Chief Executive Officer | $32,194,326↑ 35% | 95% at-risk | $1,600,000 | $23,778,578 | $4,000,000 | $15,750 |
Sam A. Eldessouky2025 compensation | Executive Vice President and Chief Financial Officer | $4,962,441↓ 27% | 84% at-risk | $777,981 | $2,514,714 | $744,000 | $15,750 |
A. Robert D. Bailey2025 compensation | Executive Vice President and Chief Legal Officer | $3,632,951 | 78% at-risk | $767,942 | $1,714,561 | $673,200 | $27,250 |
Yehia Hashad, M.D.2025 compensation | Executive Vice President of Research & Development and Chief Medical Officer | $2,789,501 | 73% at-risk | $726,116 | $1,066,839 | $700,800 | $15,750 |
Andrew J. Stewart2025 compensation | President, Global Pharmaceuticals and International Consumer | $2,500,253↓ 39% | 74% at-risk | $629,077 | $990,631 | $604,800 | $15,750 |
Pay mix: base cash incentive equity other
CD&A excerpt
Compensation discussion & analysis
Opening passage of the loaded filing's CD&A. Use Ask below to query the full text with citations.
Read the full CD&A on SEC.gov ↗
Peer comparison
Who they benchmark against
Click any peer to jump to their proxy. Peers we haven't ingested yet kick off an import on click.
2026 Peer Group
15 members · 9 in ProxyMiner
PSTV · PLUS THERAPEUTICS, INC.A · AGILENT TECHNOLOGIES, INC.ALC · ALCON INCALGN · ALIGN TECHNOLOGY INCCOO · COOPER COMPANIES, INC.XRAY · DENTSPLY SIRONA Inc.DXCM · DEXCOM INCEW · Edwards Lifesciences CorpJAZZ · Jazz Pharmaceuticals plcOGN · Organon & Co.PRGO · PERRIGO Co plcRMD · RESMED INCTFX · TELEFLEX INCVTRS · Viatris IncZBH · ZIMMER BIOMET HOLDINGS, INC.
Governance
Policy guardrails
hedging
prohibited
“We also maintain the Anti-Hedging and Anti-Pledging Policies. The Anti-Hedging Policy generally prohibits officers, directors and employees from engaging in new hedging or monetization transactions with B+L Common Shares”
pledging
prohibited
“None of our NEOs or directors holds our securities in margin accounts subject to margin sales or pledging as loan collateral.xNo repricing of underwater options — Repricing of stock options is expressly prohibited by our…”
clawback
present
“Recoupment Policy (the “Recoupment Clawback Policy”) in accordance with Rule 10D-1”
stock ownership guidelines
present
“share ownership requirements for our NEOs”
change in control
Instead, unvested equity awards accelerate on a “double-trigger” basis upon a qualifying termination of employment in connection with a change in control
“Instead, unvested equity awards accelerate on a “double-trigger” basis upon a qualifying termination of employment in connection with a change in control”
compensation consultant
independent
“independent compensation consultant”
compensation committee
Talent and Compensation Committee
“Goals are established each year by the Talent and Compensation Committee”
Performance markers
Metric facts
revenue
$14
“using a balanced portfolio of PSUs, RSUs, and Stock Options (the “2025 LTI Program”). For the annual PSUs granted in 2025, the Talent and Compensation Committee utilized a balanced approach, measuring performance using o…”
median employee compensation
$50,904
“Pay Ratio In accordance with the requirements of Section 953(b) of the Dodd-Frank Act and Item 402(u) of Regulation S-K (which we collectively refer to as the “Pay Ratio Rule”), we are providing the following estimated i…”
Ask
Anything about Bausch & Lomb Corp’s 2026 proxy
Answers are grounded in the loaded filing and cite specific artifacts. Bring your own free Google AI Studio key.
Loading the Ask interface…